Literature DB >> 9287128

Role of the prohormone convertase PC2 in the processing of proglucagon to glucagon.

Y Rouillé1, M Bianchi, J C Irminger, P A Halban.   

Abstract

Proglucagon is alternatively processed to glucagon in pancreatic alpha-cells, or to glucagon-like peptide-1 in intestinal L cells. Here, the specificity of PC2, the major prohormone convertase of alpha-cells, was examined both in vivo and in vitro. Adenovirus-mediated co-expression of proglucagon and PC2 in GH4C1 cells resulted in a pattern of processing products very similar to that observed in alpha-cells. Oxyntomodulin, an intermediate in the processing of proglucagon, was quantitatively converted to glucagon in vitro by purified recombinant PC2, in combination with carboxypeptidase E. It is concluded that PC2 is able to act alone in the pancreatic pathway of proglucagon processing.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9287128     DOI: 10.1016/s0014-5793(97)00892-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  Inhibition of prohormone convertases PC1/3 and PC2 by 2,5-dideoxystreptamine derivatives.

Authors:  Mirella Vivoli; Thomas R Caulfield; Karina Martínez-Mayorga; Alan T Johnson; Guan-Sheng Jiao; Iris Lindberg
Journal:  Mol Pharmacol       Date:  2011-12-14       Impact factor: 4.436

2.  Yapsin 1 immunoreactivity in {alpha}-cells of human pancreatic islets: implications for the processing of human proglucagon by mammalian aspartic proteases.

Authors:  Niamh X Cawley; Guida Portela-Gomes; Hong Lou; Y Peng Loh
Journal:  J Endocrinol       Date:  2011-06-01       Impact factor: 4.286

3.  Relative quantitation of neuropeptides over a thousand-fold concentration range.

Authors:  Xiaowen Hou; Fang Xie; Jonathan V Sweedler
Journal:  J Am Soc Mass Spectrom       Date:  2012-09-20       Impact factor: 3.109

4.  Mice deficient in endothelin-converting enzyme-2 exhibit abnormal responses to morphine and altered peptide levels in the spinal cord.

Authors:  Lydia K Miller; Xiaowen Hou; Ramona M Rodriguiz; Khatuna Gagnidze; Jonathan V Sweedler; William C Wetsel; Lakshmi A Devi
Journal:  J Neurochem       Date:  2011-11-01       Impact factor: 5.372

5.  Hormonal activity of AIMP1/p43 for glucose homeostasis.

Authors:  Sang Gyu Park; Young Sun Kang; Jin Young Kim; Chang Seok Lee; Young Gyu Ko; Woo Je Lee; Ki-Up Lee; Young Il Yeom; Sunghoon Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-25       Impact factor: 11.205

6.  Synthetic small-molecule prohormone convertase 2 inhibitors.

Authors:  Dorota Kowalska; Jin Liu; Jon R Appel; Akihiko Ozawa; Adel Nefzi; Robert B Mackin; Richard A Houghten; Iris Lindberg
Journal:  Mol Pharmacol       Date:  2008-12-12       Impact factor: 4.436

7.  Glucagon receptor antagonism improves islet function in mice with insulin resistance induced by a high-fat diet.

Authors:  M Sörhede Winzell; C L Brand; N Wierup; U G Sidelmann; F Sundler; E Nishimura; B Ahrén
Journal:  Diabetologia       Date:  2007-05-04       Impact factor: 10.122

8.  Immunocytochemical Localization of Prohormone Convertase 1/3 and 2 in Thyroid C-Cells and Medullary Thyroid Carcinomas.

Authors:  Tatsuo Tomita
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

9.  Transplantation of PC1/3-Expressing alpha-cells improves glucose handling and cold tolerance in leptin-resistant mice.

Authors:  Rhonda D Wideman; Sarah L Gray; Scott D Covey; Gene C Webb; Timothy J Kieffer
Journal:  Mol Ther       Date:  2008-10-21       Impact factor: 11.454

Review 10.  PCSK1 Variants and Human Obesity.

Authors:  B Ramos-Molina; M G Martin; I Lindberg
Journal:  Prog Mol Biol Transl Sci       Date:  2016-01-29       Impact factor: 3.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.